Back to Research Hub
Sionna Therapeutics, Inc.
SION
$34.26+0.75 (+2.24%)
Sionna Therapeutics, Inc. is a biopharmaceutical company. The Company provides treatment paradigm for cystic fibrosis patients by developing medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator.
StreetsValue research for Sionna Therapeutics, Inc. (SION)
Members get the full report for Sionna Therapeutics, Inc.: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.